Tong Dai, MD: Considering all the options, it looks like if the patient needs faster response, pembrolizumab plus lenvatinib ...
Low-dose pembrolizumab increased complete pathological response when added to dose-dense taxane backbone in patients with stage II to III triple-negative breast cancer,” said Atul Batra, MD.
Patients with GCA receiving combination IVMP/MTX with lower-dose prednisone had lower cumulative GC doses and fewer related side effects vs SOC.
Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CETIMA402 and IMA401 TCR Bispecifics ...
Immatics (IMTX) announced updated Phase 1a dose escalation data from both product candidates in its TCR Bispecific pipeline, IMA402 PRAME ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback